BA
ADVM

BlackRock Advisors’s Adverum Biotechnologies ADVM Stock Holding History

BlackRock Advisors’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$35K Buy
1,213
+60
+5% +$1.96K ﹤0.01% 3336
2016
Q3 		$47K Hold
1,153
– – ﹤0.01% 3267
2016
Q2 		$36K Buy
1,153
+367
+47% +$16.6K ﹤0.01% 3307
2016
Q1 		$41K Hold
786
– – ﹤0.01% 3214
2015
Q4 		$75K Sell
786
-448
-36% -$39.4K ﹤0.01% 3051
2015
Q3 		$102K Buy
1,234
+125
+11% +$16K ﹤0.01% 3091
2015
Q2 		$180K Buy
1,109
+678
+157% +$229K ﹤0.01% 2850
2015
Q1 		$175K Sell
431
-4,957
-92% -$2.1M ﹤0.01% 2753
2014
Q4 		$2.91M Buy
5,388
+33
+0.6% +$12.7K ﹤0.01% 1093
2014
Q3 		$1.83M Buy
+5,355
New +$1.59M ﹤0.01% 1199

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock Advisors's ADVM Position: Q4 2016 in Review

BlackRock Advisors increased its Adverum Biotechnologies (ADVM) stake by 5.2% in Q4 2016, buying an estimated $1.96K and bringing the position to 1,213 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #3336.

BlackRock Advisors first reported a position in ADVM in Q3 2014 and has held it in 10 quarters since. The position peaked at $2.91M in Q4 2014. 83 funds tracked by Wall St. Rank hold ADVM as of Q4 2016.

  • BlackRock Advisors held 1,213 shares of Adverum Biotechnologies worth $35K as of Q4 2016.
  • BlackRock Advisors bought 60 Adverum Biotechnologies shares in Q4 2016, an estimated $1.96K.
  • Adverum Biotechnologies made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3336 holding.
  • BlackRock Advisors first reported a position in Adverum Biotechnologies in Q3 2014 and has held it in 10 quarters since.
  • BlackRock Advisors's Adverum Biotechnologies position peaked at $2.91M in Q4 2014.
  • 83 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.